Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02909192 · ClinicalTrials.gov registry record · NA

Bright Light Therapy for Non-motor Symptoms in Parkinson's Disease

A NA study of Parkinson's Disease, sponsored by Massachusetts General Hospital.

Active
Registry status
NA
Development phase
65
Enrollment target
1
Study location

NCT02909192 is a NA study of Parkinson's Disease that is active but no longer recruiting, run by Massachusetts General Hospital. The registered enrollment target is 65 participants, below the 642-participant average among 156 other Parkinson's Disease trials with a reported enrollment target (90% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02909192, a NA study of Parkinson's Disease, is active but no longer recruiting, sponsored by Massachusetts General Hospital.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
65 participants
Enrollment target
1
Study location

Study Summary

Disruption of sleep and alertness is one of the most disabling non-motor symptoms of Parkinson's disease (PD). Mechanisms leading to impaired sleep and alertness in PD are not well understood, and treatment options remain limited. The proposed research will examine markers of the circadian system, sleepiness and sleep quality in PD patients. Further, the project will examine effects of bright light exposure on circadin function, sleep and alertness in PD.

Conditions Studied

Interventions

  • DEVICE Light Therapy Device

Study Locations (1)

Massachusetts

  • Massachusetts General Hospital - Boston

Trial Details

FieldValue
Enrollment Target 65 participants
Start Date 2016-12
Est. Completion 2026-11
Phase NA

Sponsor

Massachusetts General Hospital

2,032 total trials

What the Registry Record Tells You About NCT02909192

The ClinicalTrials.gov registry entry for NCT02909192 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 65 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 642-participant average among 156 other Parkinson's Disease trials with a reported enrollment target (90% lower). The listed sponsor is Massachusetts General Hospital, which has 2,032 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Parkinson's Disease appearing as the primary indexed condition, and to 1 intervention - of which Light Therapy Device is the first listed.

NCT02909192 reports 1 study location spanning 1 distinct geographic area - top geographies include Massachusetts.

Frequently Asked Questions

What is clinical trial NCT02909192 about?

NCT02909192 is a clinical study titled "Bright Light Therapy for Non-motor Symptoms in Parkinson's Disease". Disruption of sleep and alertness is one of the most disabling non-motor symptoms of Parkinson's disease (PD). Mechanisms leading to impaired sleep and alertness in PD are not well understood, and treatment options remain limited. The proposed research will examine markers of the circadian system, s...

What is the current status of trial NCT02909192?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 65 participants. The study started on 2016-12. Estimated completion is 2026-11.

What conditions does trial NCT02909192 study?

This clinical trial studies the following conditions: Parkinson's Disease.

What interventions are being tested in trial NCT02909192?

The interventions under investigation include: Light Therapy Device (DEVICE).

Who is sponsoring clinical trial NCT02909192?

This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02909192 being conducted?

This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Parkinson's Disease

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.